Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...

Nu Holdings stock dropped after weak Q4 earnings, but high local growth and attractive valuation signal a buy-the-dip ...

The average brokerage recommendation (ABR) for Shopify (SHOP) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...

John Ransom, Raymond James, joins 'Fast Money' to talk why he is still optimistic on UnitedHealth despite DOJ probe.

As the crypto market shifts, Qubetics, NEAR Protocol, and Polygon each present different investment opportunities; Qubetics ...

The U.S. stock market is likely headed for a correction, according to prominent Wall Street investment bank Goldman Sachs (GS ...

Goldman Sachs analyst Will Nance maintained a Buy rating on Visa (V – Research Report) today and set a price target of $384.00. The company’s ...

Komatsu Ltd. (KMTUY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader ...

Both Netflix and Meta Platforms remain prime selections for growth-focused investors, with the earnings outlook for each ...

Another ASX 200 blue chip share that could be a top buy for an SMSF is CSL. It is the biotechnology giant behind the CSL ...

All of this means Nvidia makes a great AI stock to buy ahead of Feb. 26. If the stock rises or falls after the report, that's ...